![Champions Oncology Announces its Lumin Bioinformatics Platform Selected as a Finalist for the 'Best in Show' Competition at Bio-IT World Conference & Expo Champions Oncology Announces its Lumin Bioinformatics Platform Selected as a Finalist for the 'Best in Show' Competition at Bio-IT World Conference & Expo](https://www.accesswire.com/logos/subaccounts/13638.jpg)
Champions Oncology Announces its Lumin Bioinformatics Platform Selected as a Finalist for the 'Best in Show' Competition at Bio-IT World Conference & Expo
Champions Oncology - Champions' partnership with GigaMune will combine our novel Autologous Tumor Infiltrating Lymphocyte (TIL) platform with Gigamune's T Cell Receptor (TCR) Discovery platform to accelerate next gen therapies & diagnostics.
Champions Oncology Announces its Lumin Bioinformatics Platform Selected as a Finalist for the 'Best in Show' Competition at Bio-IT World Conference & Expo
![Case Study: Champions TumorGraft® Guides the Development of a Novel, Selective Dual BRAF/EGFR Inhibitor, CEP-32496 Case Study: Champions TumorGraft® Guides the Development of a Novel, Selective Dual BRAF/EGFR Inhibitor, CEP-32496](https://www.championsoncology.com/hubfs/Case%20Studies/Landing-Page-Tumor-graft-Blur.jpg)
Case Study: Champions TumorGraft® Guides the Development of a Novel, Selective Dual BRAF/EGFR Inhibitor, CEP-32496
Champions Oncology - CJ Yu is a Senior Scientist at Champions Oncology. His role involves analyzing biomarkers within patient cancer tissues. He is passionate about integrating new technologies in his research. Learn
![Champions Oncology: Emerging Pick And Shovel Play On Cancer Drug Development (NASDAQ:CSBR) | Seeking Alpha Champions Oncology: Emerging Pick And Shovel Play On Cancer Drug Development (NASDAQ:CSBR) | Seeking Alpha](https://static.seekingalpha.com/uploads/2019/3/20/1037712-1553102662763556_origin.jpeg)